On 1 July, nearly 300 laboratory staff from across the globe - both in-person and online -gathered for our inaugural IHH Labs Town Hall.
This landmark event united our lab entities, including Premier Integrated Labs (Malaysia), Parkway Laboratories (Singapore), Acibadem Labmed (Turkiye), and Agilus Diagnostics (India), as we harness our strengths, partnerships, and capabilities to create value for our patients and partners.
In his welcome address, IHH Group CEO Dr Prem Kumar Nair praised our Labs colleagues for their dedication in shaping our vision of becoming the world’s top medical laboratory service provider.
“Let me just say how incredibly proud I am of everything we've achieved together. In just a few short years, we’ve built a global lab business that’s not only thriving but also stands as a key growth pillar of IHH Healthcare. This success story is all thanks to your hard work, dedication, and unwavering commitment to excellence. As we gather here today, I can’t help but feel a surge of excitement about our future. We’re at a pivotal moment, not just for our labs but for IHH Healthcare as a whole,” said Dr Prem.
Ashok Pandit, IHH Group Chief Corporate Officer, shared our long-term strategy for building our laboratory business.
“Our big focus is to prime our laboratory business as a distinct core business and new growth engine for IHH Healthcare, increase our market share with high-end tests and position ourselves as a regional reference laboratory in Asia,” he said.
Next, a dynamic fireside chat featuring Ashok Pandit, IHH Group Chief Corporate Officer, Prof Dr Ibrahim Unsal, COO and Chief Medical Officer of IHH Laboratories; Hareeff Muhammed, CEO of Premier Integrated Labs; Dr Shawn Ng, CEO of Parkway Laboratories; Prof Dr Mustafa Serteser, CEO of Acibadem Labmed; and Anand K, CEO of Agilus Diagnostics, moderated by Janet Low, Group Head of Communications & Branding, delved into the unique aspects, staff integration efforts, digital initiatives and upcoming plans of each lab entity.
Pauline Puay, Chief People Officer at IHH Laboratories, rounded up the townhall by emphasising IHH’s commitment to empower our teams to innovate, lead and transform healthcare.
Related Stories
.png?sfvrsn=e4a6c77e_1)
Shaping our Future, Sustainably
How do sustainability and healthcare intersect to shape our future? This was the focus of our second HealthcareInsider leadership dialogue this year, themed "Shaping our Future, Sustainably," held on 1 August 2024.
Ukrainian Baby Hears for the First Time After 15 Months
In a heartwarming moment, Leia Dynnyk, a 15-month-old from Ukraine, experienced a miracle when she heard her mother’s voice for the first time after undergoing cochlear implant surgery at Acıbadem Kent Hospital in İzmir, Türkiye.
Transforming Cancer Care with Robotic Precision
Gleneagles HealthCity Chennai recently celebrated a significant milestone in clinical excellence, completing over 100 robotic-assisted cancer surgeries within a year.
Meet Our New Chairman
On 26 June, IHH welcomed veteran business leader and lawyer Tan Sri Dr Nik Norzrul Thani bin N Hassan Thani as Chairman and Independent Non-Executive Director of IHH Healthcare.
IHH Inaugural Risk and Compliance Forum 2024
IHH held its inaugural risk and compliance forum on 2 and 3 July 2024, under the theme of "Navigating Uncertainties. Forming Resilience. Seizing Opportunities”.
Advancing Care Provision In Hong Kong
On 23 May, Parkway Medical Services (PMS) Hong Kong and Caritas – Hong Kong signed an MOU to redevelop Precious Blood Hospital. This partnership is set to elevate healthcare quality and service excellence for more people in the city.